Immunosuppressants-ligands as neuroprotectants

Transplant Proc. 2001 May;33(3):2217-9. doi: 10.1016/s0041-1345(01)01945-5.
No abstract available

Publication types

  • Review

MeSH terms

  • Cerebral Infarction / drug therapy
  • Cerebral Infarction / physiopathology
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Ligands
  • Neuroprotective Agents / therapeutic use*
  • Stroke / drug therapy
  • Stroke / physiopathology*
  • Tacrolimus / adverse effects
  • Tacrolimus / therapeutic use

Substances

  • Immunosuppressive Agents
  • Ligands
  • Neuroprotective Agents
  • Cyclosporine
  • Tacrolimus